Its high and differential upregulation in fibrotic tissues, especially in the ECM producing fibroblastic foci in IPF, and the association of elevated FN levels with pulmonary fibrosis disease progression, mark it as a potentially useful target to monitor clinical disease activity [6, 23–25]. The gene discussed is FN1; the disease is pulmonary fibrosis.